Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Prostate|June 29, 2022
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancerTakafumi Yanagisawa, Takahiro Kimura, Kenichi Hata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 13, 2023
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort studyYushi Suhara, Fumihiko Urabe, Kentaro Yoshihara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2024
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter studyFumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa, et al.
The Prostate|April 9, 2025
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched CohortTatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology|January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomyMiyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
The Prostate|April 6, 2025
PSA Absolute Value Versus PSA Response Rate: Which Is More Valuable for Estimating Survival Outcomes With ARPI Treatment for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Real-World Analyses?Tatsuya Shimomura, Naoki Otsuka, Fumihiko Urabe, et al.
Translational Andrology and Urology|June 10, 2024
Does age impact clinical outcomes of radical nephroureterectomy in the elderly?-results from a multicenter retrospective studyMimu Ishikawa, Katsuki Muramoto, Kentaro Yoshihara, et al.
The Prostate|April 17, 2026
Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine FeaturesTatsuya Shimomura, Masaya Murakami, Kanako Kasai, et al.
In Vivo (Athens, Greece)|February 26, 2025
Novel Preoperative Immune Prognostic Index for Predicting Outcomes in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaKen Shibata, Kosuke Iwatani, Y U Imai, et al.
Japanese Journal of Clinical Oncology|July 22, 2024
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter studyFumihiko Urabe, Yu Imai, Yuma Goto, et al.
Pageof 3